Advertisement
NorthEastern
NorthEastern

The Scientist

» clinical trials

Most Recent

image: Stem Cell Trial Nearly Approved

Stem Cell Trial Nearly Approved

By | February 15, 2013

The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.

0 Comments

image: Robo-Eye to Enter US Market

Robo-Eye to Enter US Market

By | February 11, 2013

A retinal prosthesis, already available in Europe, can restore partial sight to people with a genetic disorder that causes blindness.

2 Comments

image: New TB Vaccine Fails Trial

New TB Vaccine Fails Trial

By | February 4, 2013

One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.

1 Comment

image: Dung Defeats Drugs

Dung Defeats Drugs

By | January 18, 2013

Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.

0 Comments

image: Spinning Clinical Trials

Spinning Clinical Trials

By | January 16, 2013

Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.

0 Comments

image: Researchers Risk Insider Trading

Researchers Risk Insider Trading

By | January 14, 2013

Academics get paid handsome fees to consult with the financial industry, but run the risk of revealing confidential information that leads to illicit gains.

0 Comments

image: Failing Alzheimer’s Test?

Failing Alzheimer’s Test?

By | December 19, 2012

Two new studies claim that a shoddy test may have caused Alzheimer’s drugs to fail in clinical trials.

0 Comments

image: Top Science Scandals of 2012

Top Science Scandals of 2012

By | December 17, 2012

This year’s roundup of bad behavior in the life sciences and new initiatives to prevent misconduct

20 Comments

image: Chelation Therapy Under Scrutiny

Chelation Therapy Under Scrutiny

By | November 15, 2012

A clinical trial suggesting the heart benefits of the controversial treatment draws criticism from the scientific community.

6 Comments

image: BioTime Seeks Geron Stem Cell Assets

BioTime Seeks Geron Stem Cell Assets

By | November 13, 2012

Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.

1 Comment

Advertisement
QIAGEN ingenuity
QIAGEN ingenuity

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. Locating Language within the Brain
  4. Brain Keeps Watch During Sleep
Advertisement
Diagenode
Diagenode
Advertisement
RayBioTech